Rhumbline Advisers Brainsway Ltd. Transaction History
Rhumbline Advisers
- $109 Billion
- Q4 2024
A detailed history of Rhumbline Advisers transactions in Brainsway Ltd. stock. As of the latest transaction made, Rhumbline Advisers holds 21,966 shares of BWAY stock, worth $225,371. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,966
Previous 19,822
10.82%
Holding current value
$225,371
Previous $183,000
12.02%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BWAY
# of Institutions
36Shares Held
3.35MCall Options Held
0Put Options Held
0-
Masters Capital Management LLC Atlanta, GA900KShares$9.23 Million0.42% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny361KShares$3.71 Million0.01% of portfolio
-
Essex Investment Management CO LLC Boston, MA305KShares$3.13 Million0.55% of portfolio
-
Acadian Asset Management LLC Boston, MA295KShares$3.03 Million0.01% of portfolio
-
Dafna Capital Management LLC Los Angeles, CA251KShares$2.58 Million0.6% of portfolio
About Brainsway Ltd.
- Ticker BWAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,519,200
- Market Cap $169M
- Description
- Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addictio...